Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder.

Neuropsychiatr Dis Treat · 2015 · PMC4531002 · PMID 26345981

Europe PMC DOI

hedged sentence

0.0863

closest p · 1.7× alpha

0.0863

boldest claim

The sentences

did not reach statistical significanceP =0.0863so close (0.05 < p ≤ 0.1)

Recently, similar results on the same index were reported, although they did not reach statistical significance (−5.56 versus −4.67, P =0.0863). 24 In addition, Robinson et al 38 demonstrated that 40 mg per day for 1 year was also safe and well tolerated by adults with MDD.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.